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Abstract
Murine 3T3-L1 adipocytes are widely used as a cellular model of obesity. However, whereas
transfection of 3T3-L1 preadipocytes is straightforward, ectopic gene expression in mature
3T3-L1 adipocytes has proved challenging. Here, we used the pSLIK vector system to
generate stable doxycycline-inducible expression of the liver-enriched inhibitor protein
isoform of CCAAT/enhancer binding protein b (CEPB (C/EBPb-LIP)) in fully differentiated
3T3-L1 adipocytes. Because overexpression of C/EBPb-LIP impairs adipocyte differentiation,
the C/EBPb-LIP construct was first integrated in 3T3-L1 preadipocytes but expression was
induced only when adipocytes were fully differentiated. Increased C/EBPb-LIP in mature
adipocytes down-regulated C/EBPb target genes including 11b-hydroxysteroid dehydro-
genase type 1, phosphoenolpyruvate carboxykinase and fatty acid binding protein 4
but had no effect on asparagine synthetase, demonstrating that transcriptional down-
regulation by C/EBPb-LIP in 3T3-L1 adipocytes is not a general effect. Importantly, these
genes were modulated in a similar manner in adipose tissue of mice with genetically
increased C/EBPb-LIP levels. The use of the pSLIK system to conditionally express
transgenes in 3T3-L1 cells could be a valuable tool to dissect adipocyte physiology.
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Introduction
First developed almost 40 years ago from Swiss mouse
embryo cells, 3T3-L1 adipocytes (Otto & Lane 2005, Rosen
& MacDougald 2006) have proved to be an invaluable
tool, advancing our understanding of cellular mechanisms
underlying obesity-related disorders. However, introduc-
tion of nucleic acids and, consequently, the manipulation
of genes in fully differentiated 3T3-L1 adipocytes are
difficult to achieve. pSLIK plasmids, encoding a tetra-
cycline-regulated transcriptional unit in a lentivirus-based
vector backbone, were originally designed to facilitate
stable transduction of microRNA-like short hairpin RNAs
into RAW264.7 cells (Shin et al. 2006) but have not been
tested in adipocytes.
The transcription factor CCAAT/enhancer binding
protein b (CEBPB (C/EBPb)) is produced as three major
isoforms resulting from differential use of in-frame trans-
lation start sites or from proteolysis (Ossipow et al. 1993,
Welm et al. 1999, Calkhoven et al. 2000); the 38 and 35 kDa
liver-enriched activator protein isoforms (C/EBPb-LAP* and
C/EBPb-LAP respectively) and the 20 kDa liver-enriched
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inhibitor protein (LIP; C/EBPb-LIP). C/EBPb-LIP contains the
carboxyl-terminal dimerisation and DNA binding domains
but lacks the amino-terminal activation domain of C/EBPb-
LAP (Ramji & Foka 2002). Consequently, C/EBPb-LIP
represses transcription by forming either homodimers
or heterodimers with the C/EBPb-LAP isoforms or other
C/EBPs (Descombes et al. 1990, Calkhoven et al. 2000) and
manipulation of C/EBPb-LIP levels may change C/EBPb-
LIP:LAP ratio. However, the majority of reports do not
differentiate between C/EBPb isoforms, and genetic disrup-
tion of the encoding gene eliminates production of all
isoforms. While C/EBPb is well recognised as a major player
in adipocyte differentiation and metabolism, the role of
the specific isoforms, and especially the C/EBPb-LIP isoform,
is less clear. We have recently shown that genetic manipu-
lation of levels of C/EBPb-LIP in vivo changes adipose
tissue expression of the C/EBPb target gene that encodes
the glucocorticoid amplifying enzyme 11b-hydroxysteroid
dehydrogenase type 1 (Hsd11b1 (11b-HSD1); Seckl et al. 2004,
Esteves et al. 2012). However, exploration of mechanisms
in 3T3-L1 adipocytes is hindered by the impairment
of preadipocyte differentiation by C/EBPb-LIP (Yeh et al.
1995, Payne et al. 2007, Abdou et al. 2011).
Here, we have used the pSLIK system to generate stable
inducible expression of C/EBPb-LIP in 3T3-L1 adipocytes.
Increased levels of C/EBPb-LIP in 3T3-L1 adipocytes
decreased the expression of the metabolically relevant
C/EBPb target genes encoding phosphoenolpyruvate
carboxykinase (Pck1 (PEPCK)), fatty acid binding protein
4 (Fabp4 (FABP4)) and asparagine synthetase in a manner
similar to manipulation of C/EBPb-LIP in vivo.
Materials and methods
Ethics statement
All animal experiments were conducted in strict accord-
ance with internationally accepted standards of humane
animal care following prior approval by the Institutional
Animal Care and Use Committee in Berlin, Germany.
Cells and animals
Murine 3T3-L1 preadipocytes (American Type Culture
Collection (ATCC)) were maintained in DMEM (Lonza,
Cambridge, UK) supplemented with newborn calf serum
(10%; Lonza), unless otherwise stated. Adult male C/EBPb
mutant mice, heterozygous C/EBPb(C/L), homozygous
C/EBPbDuORF and respective wild-type (WT) littermate
control mice (nZ6–7/group) were generated as described
previously (Smink et al. 2009, Wethmar et al. 2010).
Stable transfection of 3T3-L1 preadipocytes
C/EBPb-LIP DNA sequence was excised from pMSV-
C/EBPb (a gift from S L McKnight and W-C Yeh), ligated
to an internal ribosome entry site (IRES) to allow for
downstream GFP expression and the resulting C/EBPb-
LIP-IRES construct was cloned into pMBA-266. C/EBPb-LIP
and control (empty) pSLIK vectors (Shin et al. 2006) were
generated by gateway recombination between a pEN
(MBA-266; ATCC) entry vector harbouring C/EBPb-LIP
or empty vector and the pSLIK-Neo destination vector
(MBA-235; ATCC). 3T3-L1 preadipocytes were transfected
with control or C/EBPb-LIP-expressing pSLIK vectors using
Lipofectamine 2000 (Invitrogen), followed by R15-day
selection of cells resistant to 1 mg/ml geneticin (Invitro-
gen). Transfection efficiency was high (data not shown)
and a total pool of transfected preadipocytes was obtained.
Both control and C/EBPb-LIP transfectants expressed GFP
in the presence of doxycycline (DOX; 1 mg/ml; Sigma) and
were further selected by cell sorting in the presence of
DOX (FACSVantage, BD Biosciences, San Jose, CA, USA).
Preadipocytes were maintained throughout in geneticin.
Differentiation of 3T3-L1 preadipocytes into adipocytes
3T3-L1 preadipocytes, cultured in the absence of DOX,
harbouring C/EBPb-LIP or control empty vector, were
induced to differentiate into mature adipocytes as
described previously (Napolitano et al. 1998). Cells were
grown to confluence, and 2 days later, they were induced
to differentiate in DMEM supplemented with 10% FCS,
0.5 mM dexamethasone, 500 mM 3-isobutyl-1-methylxan-
thine and 5 mg/ml insulin for 2 days. Thereafter, 3T3-L1
cell differentiation continued in medium supplemented
with 5 mg/ml insulin alone. Experiments were performed
8–12 days following induction of differentiation, unless
otherwise stated. DOX (1 mg/ml) was added to the medium
in the experiments designed to induce C/EBPb-LIP.
Western blot analysis
Cells were harvested in lysis buffer (0.125 M Tris–HCL,
pH 6.8, 2% SDS and 10% glycerol) in the presence of a
protease inhibitor cocktail (P2714; Sigma) and heated
at 100 8C. Electrophoresis was carried out on 4–12%
NuPage Bis–Tris gels (Invitrogen). After transfer, blots
were probed with antibodies to C/EBPb (1:500 dilution
of stock 200 mg/ml; Santa Cruz Biotechnology, Inc.)
and b-tubulin (1:10 000 dilution; Chemicon/Millipore,
Watford, UK). Secondary antibodies were anti-rabbit
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IgG-HRP (1:2000 dilution from stock 400 mg/ml; Santa
Cruz Biotechnology, Inc.), anti-mouse IgG-HRP (1:4000
dilution; Cell Signaling, Danvers, MA, USA), anti-rabbit
IgG Alexa Fluor 700 (Invitrogen) or anti-mouse IgG 488
Conjugated (Rockland Immunochemicals, Inc., Gilbertsville,
PA, USA). The resulting bands were visualised on
X-ray films developed in a Konica SRX-101 X-Ray
developer or using the Odyssey Infrared Imaging System,
as appropriate.
Oil Red O staining
3T3-L1 adipocytes were stained by Oil Red O as described
previously (Lillie & Ashburn 1943) with modifications.
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Figure 1
The pSLIK-C/EBPb-LIP construct and generation of stably transfected 3T3-L1
preadipocytes. (A) Schematic representation of the pSLIK Tet-On empty
vector (top; vector, pSLIK) and construct used to generate stable 3T3-L1
preadipocytes conditionally overexpressing C/EBPb-LIP (bottom; LIP, pSLIK-
C/EBPb-LIP). C/EBPb-LIP and GFP are co-expressed from the same transcript.
The constitutively active ubiquitin c (Ubi-c) promoter drives expression of
the Tet activator (rtTA3) and neomycin resistance gene (Neo; for selection).
Addition of DOX causes binding of rtTA3 to the TRE/CMV promoter (TRE),
inducing expression of GFP or C/EBPb-LIP-IRES-GFP. (B) FACS analysis and
sorting of 3T3-L1 preadipocytes (5!106 cells) stably transfected with
pSLIK-C/EBPb-LIP (LIP) or pSLIK vector (vector) following DOX treatment
(1 mg/ml, 24 h) to induce GFP. Upper panels, forward scatter (FSC) vs side
scatter (SSC) dot plots, showing the populations of single cells (circled) that
were analysed and sorted for GFP expression (FSC vs GFP intensity plots;
middle row of panels) and histogram showing the number of cells for GFP
intensity (lower panels). Middle and lower panels show the enrichment of
GFP-positive cells for both pSLIK-C/EBPb-LIP and pSLIK cells after sorting
(right panels) resulting from the removal of low or non-GFP-expressing
preadipocytes (arrow; left panels).
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Cells were immersed in isopropanol (60%), followed by the
staining solution (0.04% Oil Red O in 60% isopropanol) and
ammonia (1%) and then visualised using a Zeiss Axioskop
microscope. Quantification of Oil Red O staining density
was performed with ImageJ (NIH, Bethesda, MA, USA).
RNA extraction and real-time PCR
Cells were harvested in TRIzol (Invitrogen) and RNA
was extracted according to the manufacturer’s protocol.
Mouse subcutaneous adipose tissue was dissected and
frozen (K70 8C) prior to RNA extraction using Qiagen
RNeasy Lipid Tissue Mini kit (Qiagen). RNA (1 mg) was
reverse transcribed using SuperScript III (Invitrogen),
and specific mRNAs were quantified by real-time PCR
using a LightCycler 480 (Roche) as described (Sai et al.
2008). Primer–probe sets were purchased from Applied
Biosystems: C/EBPb (Mm00843434_s1), 11b-HSD1
(Mm00476182_m1), PEPCK (Mm01247058_m1), FABP4
(Mm00445878_m1) and asparagine synthetase (Mm
00803785_m1). TATA binding protein (TBP; Mm
00446973_m1) was used as internal control and did not
change with treatment or between groups.
Statistical analysis
All data were analysed by Student’s t-test or one-way
ANOVA followed by post hoc least square difference test
using SigmaStat 2.03 Statistical Software. Significance
was set at P%0.05.
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Figure 2
Doxycycline-inducible expression of C/EBPb-LIP in fully differentiated
adipocytes and adipocyte differentiation visualised by Oil Red O staining.
(A) Western blot showing induction of C/EBPb-LIP expression in 3T3-L1
pSLIK-C/EBPb-LIP (LIP, CDOX) or pSLIK control vector (vector,CDOX)
adipocytes. Preadipocytes were differentiated into adipocytes in DOX-free
medium. Mature adipocytes were then treated with DOX for 2 days. In the
absence of DOX, C/EBPb-LIP levels were not elevated above basal
endogenous levels in pSLIK-C/EBPb-LIP adipocytes (LIP,KDOX). The blot
(40 mg protein/lane) was probed with C/EBPb antibody (38 kDa LAP*,
35 kDa LAP and 20 kDa LIP are indicated), then stripped and reprobed with
b-tubulin antibody, as loading control. All samples in each membrane were
analysed in the same gel, but not in adjacent lanes. (B) Western blot
showing robust induction of C/EBPb-LIP in pSLIK-C/EBPb-LIP adipocytes,
previously differentiated in DOX-free medium and then treated with DOX
between days 0 and 2. Samples (50 mg protein/lane) were taken before
treatment (0), 2 days after DOX-induction of C/EBPb-LIP (2; CDOX) and
2 and 5 days following DOX withdrawal from the medium (2 and 5;KDOX).
(C and D) Oil Red O staining showing lipid accumulation in differentiated
adipocytes. 3T3-L1 pSLIK-C/EBPb-LIP preadipocytes were differentiated into
adipocytes in the presence (CDOX) or absence (KDOX) of DOX (C) or were
differentiated in the absence of DOX and then DOX-treated for 3 days prior
to Oil Red O staining (D). Panels show differentiated adipocytes; pSLIK-
C/EBPb-LIP (LIP; b), pSLIK control vector (vector; a) and untransfected 3T3-L1
adipocytes (c). Objective magnification,!10.
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Results
Conditional expression of C/EBPb-LIP in stably transfected
3T3-L1 preadipocytes and differentiated adipocytes
To generate a vector to conditionally express C/EBPb-LIP,
the encoding cDNA was cloned and recombined in the
MBA-266 and the pSLIK-Neo MBA-235 vectors, respectively,
producing the pSLIK-C/EBPb-LIP vector in which a tetra-
cycline response element drives expression of C/EBPb-LIP
from a minimal CMV promoter in the presence of DOX
(a Tet-ON system) and a contiguous IRES allows for GFP
expression. Constitutive expression of the reverse Tet
transactivator (rtTA3) and the neomycin resistance gene
(Neo) is driven by the ubiquitin-c (Ubi-c) promoter (Fig. 1A).
In order to express C/EBPb-LIP in mature adipocytes, we first
generated stably transfected 3T3-L1 preadipocytes that, in
contrast to fully differentiated adipocytes, could be readily
transfected with pSLIK-C/EBPb-LIP or the ‘empty’ vector.
This was highly efficient allowing selection of transfectants
with geneticin as a total pool of cells, avoiding clonal
differences due to plasmid integration site. To ensure that
only transfected cells were used in the subsequent experi-
ments, preadipocytes were sorted by flow cytometry for GFP
expression 24 h after incubation with DOX, with yields of
26 and 56% for pSLIK-C/EBPb-LIP and pSLIK-transfectants
respectively (Fig. 1B). In the absence of DOX, only 0.9% of
pSLIK-C/EBPb-LIP and 4.3% of pSLIK preadipocytes were
GFP positive, demonstrating low spontaneous expression
in the transfected preadipocytes. pSLIK-C/EBPb-LIP preadi-
pocytes were then differentiated into mature adipocytes
in DOX-free medium (to avoid the inhibitory effects of
C/EBPb-LIP upon adipocyte differentiation) and subsequent
DOX treatment robustly increased cellular C/EBPb-LIP levels
in the mature adipocytes (Fig. 2A and B). Following removal
of DOX from the cell medium, C/EBPb-LIP decreased as
expected, showing that it can be transiently induced
(Fig. 2B). Importantly, in the absence of DOX, pSLIK-
C/EBPb-LIP adipocytes showed comparable low endogen-
ous levels of C/EBPb-LIP to control adipocytes harbouring
the pSLIK empty vector (Fig. 2A).
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Figure 3
Elevated adipocyte C/EBPb-LIP represses expression of C/EBPb target genes
but not of asparagine synthetase. Real-time PCR measurement of levels of
mRNAs encoding (A) 11b-HSD1, (B) PEPCK, (C) FABP4 and (D) asparagine
synthetase in 3T3-L1 pSLIK-C/EBPb-LIP adipocytes (black bars) compared
with pSLIK control adipocytes (white bars), following 1–4 days of induction
with DOX. Preadipocytes were differentiated into adipocytes in DOX-free
medium and DOX was added to mature adipocytes to induce C/EBPb-LIP
expression. Levels of specific mRNAs, normalised to TBP are expressed
relative to levels in pSLIK adipocytes (arbitrarily set to 100%). Data are
meanGS.E.M. of two independent adipocyte differentiations, each carried
out in triplicate. *Significantly different from pSLIK control adipocytes.
*P%0.05, **P!0.001 and ***P!0.0001.
Jo
u
rn
a
l
o
f
M
o
le
cu
la
r
E
n
d
o
cr
in
o
lo
g
y
Research C L ESTEVES and others Stable expression of C/EBPb-LIP
in adipocytes
51 :1 95
http://jme.endocrinology-journals.org
DOI: 10.1530/JME-13-0029
 2013 The authors
Printed in Great Britain
Published by Bioscientifica Ltd
3T3-L1 preadipocytes stably transfected with
pSLIK-C/EBPb-LIP differentiate normally into adipocytes
Consistent with previous data (Yeh et al. 1995, Payne et al.
2007, Abdou et al. 2011), adipocyte differentiation (demon-
strated by Oil Red O staining of lipid) was markedly
attenuated if C/EBPb-LIP expression was induced in 3T3-
L1 pSLIK-C/EBPb-LIP preadipocytes prior to and during
differentiation by DOX (Fig. 2C). In contrast, when pSLIK-
C/EBPb-LIP preadipocytes were differentiated in the absence
of DOX, both pSLIK control and pSLIK-C/EBPb-LIP pre-
adipocytes differentiated normally into mature adipocytes.
Induction of C/EBPb-LIP in fully differentiated adipocytes
had no effect on their differentiation status as shown by
quantification of Oil Red O staining (Fig. 2D).
Increased C/EBPb-LIP reduces expression of 11b-HSD1,
PEPCK and FABP4 but not asparagine synthetase
in 3T3-L1 mature adipocytes
The transcriptional impact of increased C/EBPb-LIP in adipo-
cytes was examined following induction with DOX only once
3T3-L1 adipocytes were fully differentiated. Concurrent with
the increase in C/EBPb-LIP expression, and consequently
C/EBPb-LIP:LAP ratio, DOX reduced 11b-HSD1 and PEPCK
mRNA levels in 3T3-L1 pSLIK-C/EBPb-LIP adipocytes compa-
red with control cells (Fig. 3A and B). FABP4 mRNA levels were
decreased following 4 days of DOX treatment but asparagine
synthetase mRNA levels were unaffected (Fig. 3C and D).
Modulation of C/EBPb-LIP levels in adipose tissue
in vivo changes the expression of PEPCK and FABP4
To test the relevance of the 3T3-L1 pSLIK-C/EBPb-LIP
adipocyte model to the in vivo situation, we measured the
levels of mRNA encoding PEPCK, FABP4 and asparagine
synthetase in the adipose tissue of mice genetically
engineered to produce altered levels of C/EBPb-LIP,
which we have previously shown to regulate adipose
tissue 11b-HSD1 mRNA levels (Esteves et al. 2012).
C/EBPb(C/L) mice, with a ‘knock-in’ of C/EBPb-LIP
(L allele) replacing the normal C/EBPb gene, have increased
C/EBPb-LIP levels and therefore increased C/EBPb-LIP:LAP
ratio (Smink et al. 2009). In contrast, in C/EBPbDuORF mice,
deletion of the upstream open reading frame (DuORF
allele) prevents translation of C/EBPb-LIP (Wethmar et al.
2010), resulting in decreased C/EBPb-LIP:LAP ratio
(Esteves et al. 2012). In agreement with the results
obtained in the 3T3-L1 pSLIK-C/EBPb-LIP adipocytes,
levels of mRNA encoding PEPCK were lower in the adipose
tissue of C/EBPb(C/L) mice compared with C/EBPbDuORF
(Fig. 4A). However, there was no significant decrease in
PEPCK mRNA levels in C/EBPb(C/L) mice compared with
WT controls, suggesting a larger effect of C/EBPb-LIP
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Figure 4
Elevated C/EBPb-LIP represses expression of PEPCK and FABP4, but
not asparagine synthetase in adipose tissue in vivo. Real-time PCR
measurement of levels of mRNA encoding (A) PEPCK, (B) FABP4 and
(C) asparagine synthetase in adipose tissue of wild-type control mice
(Con, white bars), C/EBPb(C/L) (C/L, black bars) and C/EBPbDuORF (DuORF,
grey bars). C/EBPb(C/L) mice are heterozygous for an allele of C/EBPb in
which the normal gene has been replaced by C/EBPb-LIP (a ‘knock-in’;
Smink et al. 2009) and C/EBPbDuORF mice have a homozygous disruption
of the upstream ORF (Wethmar et al. 2010). Adipose tissue mRNA
levels, normalised to TBP, are expressed relative to levels in control mice
(arbitrarily set to 100%) and are meanGS.E.M.; nZ6–9/group. *P%0.05.
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in vitro than in vivo or that compensation has occurred
in vivo (e.g. through tissues other than adipose). FABP4
levels were lower in the adipose of C/EBPb(C/L) mice
compared with control and C/EBPbDuORF mice, while
asparagine synthetase was unchanged (Fig. 4B and C).
Taken together, these results show that the 3T3-L1 pSLIK-
C/EBPb-LIP adipocytes mimic the in vivo regulation.
Discussion
The use of the pSLIK system to conditionally express
C/EBPb-LIP in fully differentiated 3T3-L1 mature adipo-
cytes allowed investigating its impact on the transcrip-
tional levels of 11b-HSD1, PEPCK, FABP4 and asparagine
synthetase in these cells. Although transfection of
adipocytes with small RNAs (siRNA and shRNA) has
recently been achieved using nanoparticles of virus-
derived amphipathic peptides (Li et al. 2007, Esteves
et al. 2012), transfection of vectors harbouring expression
cassettes remains a challenge. Electroporation, used in
some studies (Thurmond et al. 1998), causes high levels of
adipocyte death, is inefficient, and requires large amounts
of DNA (or RNA). Adenovirus transduction allows
expression of exogenous genes in 3T3-L1 adipocytes
(Gnudi et al. 1997, Boizard et al. 1998, Duong et al. 2002,
Carlotti et al. 2004) but does not produce stable expression
and can induce immune responses. Many genes expressed
in adipocytes, including 11b-HSD1 (Chapman et al. 2009),
are immunoresponsive (Shoelson et al. 2006). Lentiviral
vectors can be used to stably transduce adipocytes but
require production of high titres of virus (Carlotti et al.
2004, Liao et al. 2006). The pSLIK vector used in the
current study was originally designed as an intermediate
in lentiviral construction (Shin et al. 2006) and combines
all components required for expression (Tet-ON) and
selection (Neo, GFP) in a single plasmid vector. This
allows for the transfection of the pSLIK-C/EBPb-LIP vector
into 3T3-L1 preadipocytes without the need for lentivirus
and proves a highly efficient process. Here, we used DOX
to restrict expression of C/EBPb-LIP to fully differentiated
3T3-L1 adipocytes, but ectopic transgene expression can
be initiated at any stage of 3T3-L1 adipocyte differen-
tiation or even induced transiently. Moreover, it may
prove useful for expression of shRNA in differentiated
adipocytes, to conditionally knockdown gene expression.
Contrary to standard lentiviral transduction of adipocytes,
here, all adipocytes harbour the gene of interest and
expression is achieved soon after induction with DOX.
Elevation of C/EBPb-LIP in mature differentiated 3T3-L1
adipocytes concomitantly decreased PEPCK and 11b-HSD1
mRNA levels, suggesting direct regulation of 11b-HSD1 by
C/EBPb-LIP in adipocytes. Indeed, both genes are bound
by C/EBPb and this has been shown for 11b-HSD1 in several
cell types (Arai et al. 2007, Sai et al. 2008, Yang et al. 2009),
including adipocytes (Esteves et al. 2012), and for PEPCK
in hepatoma cells (Park et al. 1993, Choudhury et al. 2011).
PEPCK mRNA levels declined faster than other genes,
possibly reflecting the short half-life of PEPCK (Tilghman
et al. 1974) compared with 11b-HSD1 mRNA, for example
(Balachandran et al. 2008). FABP4 mRNA levels were only
affected after more prolonged elevation of C/EBPb-LIP,
suggesting that either the mRNA is very stable or regulation
is indirect. However, C/EBPb-LIP expression did not depress
global transcription in adipocytes, as asparagine synthetase
mRNA levels were unaffected by elevated adipocyte C/EBPb-
LIP both in vitro and in vivo. This contrasts with the HepG2
hepatoma cells where asparagine synthase is regulated by
the C/EBPb-LIP:LAP ratio (Siu et al. 2001) and might reflect
differences in epigenetic regulation.
Finally, we note that this system may be of broader
application to explore the role of other adipocyte relevant
genes in fully differentiated adipocytes, providing insights
into their effect on adipocyte physiology.
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